ATG7 deficiency causes p53 activation, accumulation of defective mitochondria, proliferative defects, reduced tumor burden, conversion of adenomas and adenocarcinomas to oncocytomas, and increased mouse survival (51, 52). The gene discussed is TP53; the disease is neoplasm.